Measurement of the mitochondrial apoptosis pathway

LF Lisa C. Flores
MR Madeline G. Roman
GC Geneva M. Cunningham
CC Christie Cheng
SD Sara Dube
CA Colton Allen
HR Holly Van Remmen
GH Gene B. Hubbard
TS Thomas L. Saunders
YI Yuji Ikeno
ask Ask a question
Favorite

The mitochondrial apoptosis pathway was assessed by measuring caspase activity, cytochrome c release from the mitochondria, and bcl-2 levels in the liver obtained from young (6–7 months old) Tg(TXN)+/0 and WT mice. The caspase activities, cytochrome c release, and bcl-2 levels were determined by Western blot assay. The caspase-3 activity in liver tissue were visualized by the cleavage forms of caspase-3 (p20) as an indicator of caspase activity using anti-caspase-3 antibody (Cell Signaling Technology, Inc., Danvers, MA). The intensities of cleavage bands corresponding to p20 for caspase-3 were quantified by densitometry using ImageQuant v5.0, and β-actin was used as a loading control. The cytochrome c release from mitochondria was measured as levels of cytochrome c in the cytosolic fractions from liver. Equal amounts of protein were separated on a 4–20% SDS-polyacrylamide gel, transferred to nitrocellulose membranes, and subjected to Western blotting with an anti-cytochrome c antibody (Santa Cruz Biotechnology, Santa Cruz, CA). The bcl-2 levels were also measured by Western blot using anti-bcl-2 antibody (Cell Signaling Technology, Inc., Danvers, MA). Data were normalized to β-actin loading controls. The data were expressed as relative units respective to β-actin.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A